Clinical Trial Update: Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial

View source ↗

Summary

This clinical trial investigates cancer stem cell biomarkers as predictors of response to trastuzumab in breast cancer patients who were previously treated in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Status: UNKNOWN